Hemangioma, Capillary: Clinical Trials

3 trials for Hemangioma, Capillary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1

Follow Hemangioma, Capillary: new trials by email Literature Review of Hemangioma, Capillary trials Research Report on Hemangioma, Capillary

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)
Vorinostat - Von Hippel-Lindau Disease
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)72014-04-052018-09-14
Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
topical 0.5% Timolol maleate, Control (placebo) group - Infantile Hemangioma, Very Low Birth Weight Infants
Phase 1TerminatedAlice K. Gong262012-07-012016-11-15
Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
Pulsed Dye Laser 577 nm, Pulsed Dye Laser 595 nm - Port Wine Stains
Phase 1CompletedUniversity of California, Irvine562007-03-012022-10-20

Narrower conditions

Hemangioblastoma (1)  ·  Premature Birth (1)  ·  Vascular Malformations (1)  ·  von Hippel-Lindau Disease (1)

Broader conditions

Hemangioma (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Vascular Tissue (3)  ·  Cardiovascular Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Abnormalities, Multiple (1)  ·  Angiomatosis (1)  ·  Cardiovascular Abnormalities (1)  ·  Ciliopathies (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)  ·  Nervous System Diseases (1)

Interventions

Lasers, Dye (1)  ·  Population Groups (1)  ·  Timolol (1)  ·  Vorinostat (1)

Sponsors

Alice K. Gong (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  University of California, Irvine (1)

Countries

United States (3)

Top investigators

Alice K Gong, M.D. (1)  ·  Alice K Gong, MD (1)  ·  John S Nelson, M.D., Ph.D. (1)  ·  Prashant Chittiboina, M.D. (1)

Results publications

PMID 37018064